Literature DB >> 28523535

Self-protection against triptolide-induced toxicity in human hepatic cells via Nrf2-ARE-NQO1 pathway.

Ling-Ling Zhou1, Cong Zhou1,2, Xiao-Wen Liang3, Zhe Feng1, Zhang-Pu Liu1, Hao-Lu Wang3, Xue-Ping Zhou4.   

Abstract

OBJECTIVE: To find the signaling pathway of triptolide (TP)-induced liver injury and to reveal whether NF-E2-related factor 2 (Nrf2) plays an important role in cellular self-protection.
METHODS: The L-02 and HepG2 cells were cultured and treated with various concentrations of TP. The cell viability was observed, and the cell medium was collected for detecting the aspartate aminotransferase (ALT), alanine aminotransferase (AST), lactate dehydrogenase (LDH), superoxide dismutase (SOD) and L-glutathione production (GSH) levels. Nrf2 and its downstream target NAD(P)H: quinine oxidoreductase 1 (NQO1) and heme oxygenase-1 (HO-1) expression, the nuclear translocation of Nrf2, and the binding ability of Nrf2 and antioxidant response element (ARE) were also identified. Meanwhile, shRNA was used to silence Nrf2 in L-02 cells to find out whether Nrf2 plays a protective role.
RESULTS: The viability of the L-02 and HepG2 cells treated with TP decreased in a doseand time-dependent manner, and TP (20-80 μg/mL) markedly induced the release of ALT, AST and LDH (P<0.05 or P<0.01), reduced the levels of SOD and GSH (P<0.01), and increased the intracellular reactive oxygen species. Meanwhile, TP augmented the Nrf2 expression in L-02 and HepG2 cells (P<0.05 or P<0.01), induced Nrf2 nuclear translocation, increased the Nrf2 ARE binding activity, and increased HO-1 and NQO1 expressions. Nrf2 knockdown revealed a more severe toxic effect of TP (P<0.05 or P<0.01).
CONCLUSIONS: Human hepatic cells treated with TP induced oxidative stress, and led to cytotoxicity. Self-protection against TP-induced toxicity in human hepatic cells might be via Nrf2-ARE-NQO1 transcriptional pathway.

Entities:  

Keywords:  NF-E2-related factor 2; liver injury; oxidative stress; triptolide, human hepatic cells

Mesh:

Substances:

Year:  2017        PMID: 28523535     DOI: 10.1007/s11655-017-2546-6

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  23 in total

1.  Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway.

Authors:  Kyu Yeon Hur; Soo Hyun Kim; Min-Ah Choi; Darren R Williams; Yong-ho Lee; Sang Won Kang; Umesh C S Yadav; Satish K Srivastava; Mankil Jung; Jin Won Cho; Sang Geon Kim; Eun Seok Kang; Eun Jig Lee; Hyun Chul Lee
Journal:  Atherosclerosis       Date:  2010-02-02       Impact factor: 5.162

Review 2.  Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases.

Authors:  Rui Han; Martin Rostami-Yazdi; Sascha Gerdes; Ulrich Mrowietz
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

3.  Role of Nrf2 in protection against triptolide-induced toxicity in rat kidney cells.

Authors:  Jia Li; Jing Jin; Mei Li; Cuiwen Guan; Wenwen Wang; Shaohua Zhu; Yuwen Qiu; Min Huang; Zhiying Huang
Journal:  Toxicol Lett       Date:  2012-07-20       Impact factor: 4.372

4.  The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle.

Authors:  Zhinan Mei; Xiaokuan Li; Qunrong Wu; Sheng Hu; Xiangliang Yang
Journal:  Pharmacol Res       Date:  2005-04       Impact factor: 7.658

Review 5.  Nrf2-Keap1 defines a physiologically important stress response mechanism.

Authors:  Hozumi Motohashi; Masayuki Yamamoto
Journal:  Trends Mol Med       Date:  2004-11       Impact factor: 11.951

Review 6.  Triptolide: progress on research in pharmacodynamics and toxicology.

Authors:  Xiao-Jiaoyang Li; Zhen-Zhou Jiang; Lu-yong Zhang
Journal:  J Ethnopharmacol       Date:  2014-06-13       Impact factor: 4.360

7.  Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin.

Authors:  Shunsuke Tanigawa; Makoto Fujii; De-Xing Hou
Journal:  Free Radic Biol Med       Date:  2007-02-28       Impact factor: 7.376

8.  Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease.

Authors:  Stephanie J Leuenroth; Dayne Okuhara; Joseph D Shotwell; Glen S Markowitz; Zhiheng Yu; Stefan Somlo; Craig M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

9.  Protective Effect of Ethyl Acetate Fraction of Stereospermum Suaveolens Against Hepatic Oxidative Stress in STZ Diabetic Rats.

Authors:  Thirumalaiswamy Balasubramanian; G P Senthilkumar; M Karthikeyan; Tapan Kumar Chatterjee
Journal:  J Tradit Complement Med       Date:  2013-07

10.  Activation of Nrf2 protects against triptolide-induced hepatotoxicity.

Authors:  Jia Li; Feihai Shen; Cuiwen Guan; Wenwen Wang; Xiaozhe Sun; Xinlu Fu; Min Huang; Jing Jin; Zhiying Huang
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

View more
  4 in total

Review 1.  The molecular pathogenesis of triptolide-induced hepatotoxicity.

Authors:  Yeqing Hu; Qiguo Wu; Yulin Wang; Haibo Zhang; Xueying Liu; Hua Zhou; Tao Yang
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

2.  Mechanisms of Triptolide-Induced Hepatotoxicity and Protective Effect of Combined Use of Isoliquiritigenin: Possible Roles of Nrf2 and Hepatic Transporters.

Authors:  Zhenyan Hou; Lei Chen; Pingfei Fang; Hualin Cai; Huaibo Tang; Yongbo Peng; Yang Deng; Lingjuan Cao; Huande Li; Bikui Zhang; Miao Yan
Journal:  Front Pharmacol       Date:  2018-03-16       Impact factor: 5.810

Review 3.  Nephrotoxicity of Herbal Medicine and Its Prevention.

Authors:  Xiaofen Xu; Ruyi Zhu; Jialiang Ying; Mengting Zhao; Xin Wu; Gang Cao; Kuilong Wang
Journal:  Front Pharmacol       Date:  2020-10-15       Impact factor: 5.810

4.  Ginsenoside Rb1 Attenuates Triptolide-Induced Cytotoxicity in HL-7702 Cells via the Activation of Keap1/Nrf2/ARE Pathway.

Authors:  Hulinyue Peng; Longtai You; Chunjing Yang; Kaixin Wang; Manting Liu; Dongge Yin; Yuchen Xu; Xiaoxv Dong; Xingbin Yin; Jian Ni
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.